Keith Aaronson, MD
Basic profileAdvanced Heart Failure and Transplant Cardiology
Keith Aaronson is a Cardiology physician. ClinicalTrials.gov lists 5 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1500 E Medical Center Dr
Ann Arbor, MI 481095000
Telephone
734-936-4000Provider last certified this registry record 5 Dec 2025.
Clinical trials
- SCD for CRS in Congestive Heart Failure (CHF) (No Left Ventricular Assist Device)
Sponsor: Lenar Yessayan
- REGISTRY EVALUATION OF VITAL INFORMATION FOR VADs IN AMBULATORY LIFE
Sponsor: University of Michigan
- Evaluation of the HeartWare Left Ventricular Assist Device for the Treatment of Advanced Heart Failure
Sponsor: Medtronic Cardiac Rhythm and Heart Failure
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Medtronic, Inc.Program year20226 payments
- Medtronic, Inc.Program year20215 payments
- Abbott LaboratoriesProgram year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
3 NIH research awards on record, funded 1998–2015 per NIH RePORTER. The latest:
- RANDOMIZED EVALUATION OF VAD INTERVENTION BEFORE INTROPIC THERAPY (REVIVE-IT) PI
University of Michigan at Ann Arbor
FY2015$1,041,360268201100026C - RANDOMIZED EVALUATION OF VAD INTERVENTION BEFORE INTROPIC THERAPY (REVIVE-IT) PI
University of Michigan at Ann Arbor
FY2011$4,952,781268201100026C - CLINICAL TRIAL OF CRATAEGUS OXYCANTHA EXTRACT IN CHRONIC HEART FAILURE
University of Michigan at Ann Arbor
FY2005$3,088M01RR000042
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”